Search

everythinglearnresearchcommunity

for

Search:↓

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Ulcerative colitis can cause skin issues due to immune system problems.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Higher IL-17A levels indicate more severe alopecia areata.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.